Marilyn B. Kroeger Smith

Author

Also Known As

M Smith, M. B. Kroeger Smith, M. Smith, Marilyn B Kroeger Smith, Marilyn B. Kroeger Smith, Marilyn B.Kroeger Smith, Marilyn Smith

Publications

581

Citations

H-Index

Concepts

All Affiliations

McDaniel College Yale University Janssen (Belgium)Rutgers, The State University of New Jersey Cancer Research Center

About

Marilyn B. Kroeger Smith is an author at McDaniel College specializing in hiv, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	245
2	Engineering	3	3	81
3	Biochemistry	2	2	224
4	Natural Sciences	1	1	187
5	Social Sciences	1	1	33

Marilyn B. Kroeger Smith

Publications

542

Citations

H-Index

Page 1

	Year	Citations
Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant Kalyan Das, Jianping Ding, Y. Hsiou, Journal of Molecular Biology Wild-type Hiv-1 RtBiochemistry9-Cl Tibo ComplexedNatural SciencesHuman Retrovirus	1996	187
Prediction of Activity for Nonnucleoside Inhibitors with HIV-1 Reverse Transcriptase Based on Monte Carlo Simulations Robert C. Rizzo, Marina Udier–Blagović, Deping Wang, Journal of Medicinal Chemistry	2002	88
Prediction of Binding Affinities for TIBO Inhibitors of HIV-1 Reverse Transcriptase Using Monte Carlo Simulations in a Linear Response Method Richard H. Smith, William L. Jorgensen, Julian Tirado‐Rives, Journal of Medicinal Chemistry	1998	80
Molecular modeling studies of HIV‐1 reverse transcriptase nonnucleoside inhibitors: Total energy of complexation as a predictor of drug placement and activity Marilyn B. Kroeger Smith, Stephen H. Hughes, Paul L. Boyer, Protein Science	1995	60
Molecular Modeling Calculations of HIV-1 Reverse Transcriptase Nonnucleoside Inhibitors: Correlation of Binding Energy with Biological Activity for Novel 2-Aryl-Substituted Benzimidazole Analogues Marilyn B. Kroeger Smith, Brian M. Hose, Arie Hawkins, Journal of Medicinal Chemistry EngineeringComputational ChemistryPhysical DescriptorsAntiviral DrugMolecular Dynamics	2003	37
Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity Marilyn B. Kroeger Smith, Michelle L. Lamb, Julian Tirado‐Rives, Protein Engineering Design and Selection	2000	36
TIME SCALE FOR FOREST REGROWTH : ABANDONED GRAZING AND AGRICULTURAL AREAS IN SOUTHERN NORWAY Hans Staaland, Øystein Holand, Christian Nellemann, AMBIO EngineeringRangeland ProductivityForest RestorationLand UseForest Conservation	1998	33
Molecular modeling of HIV-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase action Marilyn B. Kroeger Smith, C.J. Michejda, S H Hughes, Protein Engineering Design and Selection Viral ReplicationEngineeringViral Polymerase MechanismMolecular BiologyAntiviral Drug	1997	11
Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1. Marilyn B. Kroeger Smith, Horacio Salomón, Wainberg Ma PubMed ImmunologyPharmacotherapyAntiviral DrugHuman Immunodeficiency VirusDrug Resistance	1994	10

Page 1